Latest news with #NuScalePower
E&E News
a day ago
- Business
- E&E News
NuScale secures NRC approval for second small reactor design
Nuclear developer NuScale Power on Thursday won approval from federal regulators for its second small modular reactor design. Under pressure to act more quickly on advanced reactors, the Nuclear Regulatory Commission completed its technical review of NuScale's 77-megawatt US460 SMR in just under two years. NuScale, an Oregon-based nuclear startup, holds the only other SMR standard design approval from the NRC, granted in 2020. 'This completes the NRC's technical review ahead of schedule and under budget, demonstrating the agency's commitment to safely and efficiently enable new, advanced reactor technology,' the agency said in a statement. Advertisement SMRs are less than one-tenth the size of conventional nuclear plants. They're built in factories and can be put together to form a six-pack of mini nuclear reactors, a process that nuclear advocates say will drive down costs and speed up delivery of new electricity supplies.
Yahoo
2 days ago
- Business
- Yahoo
Why NuScale Power Corporation (SMR) Went Up On Tuesday
We recently published a list of . In this article, we are going to take a look at where NuScale Power Corporation (NYSE:SMR) stands against other best-performing stocks. NuScale Power rallied for a second day on Tuesday, jumping 17.46 percent to close at $35.52 apiece as investors gobbled up shares following President Donald Trump's executive orders to ramp up the development of nuclear power technologies in the US. In particular, NuScale Power Corporation (NYSE:SMR) earned a boost from an order deploying advanced nuclear reactor technologies, which the latter is heavily investing in. A copy of the order said that the deployment will support the government's national security objectives, such as the protection and operation of critical infrastructure, critical defense facilities, and other mission capability resources, as well as enable private sector investment, innovation, development, and use of nuclear technologies across the US. A Nuclear power plant with all its safety & security protocols in place. In the first quarter of the year, NuScale Power Corporation (NYSE:SMR) increased its revenues by 857 percent to $13.4 million from $1.4 million in the same period last year on the back of revenues generated from the FEED Phase 2 project and the Technology License Agreement for the RoPower Doicești power plant. Overall, SMR ranks 4th on our list of best-performing stocks. While we acknowledge the potential of SMR, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than SMR and that has 10,000x upside potential, check out our report about this cheapest AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey.
Nikkei Asia
4 days ago
- Business
- Nikkei Asia
Japan's IHI banks on Romanian project to maintain nuclear expertise
TOKYO -- IHI has completed a prototype component for a next-generation nuclear plant in Romania, the Japanese industrial group said Tuesday, viewing the power project as a chance to maintain its technology and expertise in the field as the industry in Japan stalls. The company finished a mock-up of a side wall module for the reactor building of a small modular reactor (SMR) to be built by U.S. partner NuScale Power, in which IHI holds a stake. The steel structure will be filled with cement and installed as part of the wall.
Yahoo
5 days ago
- Business
- Yahoo
3 Monster Stocks to Hold for the Next 10 Years
Mankind's return to the moon is a major opportunity for Intuitive Machines. AI data centers are consuming more electricity than utility companies were planning on providing. NuScale Power offers a much-needed solution. The era of AI-powered drug development is upon us, with Recursion Pharmaceuticals leading the charge. 10 stocks we like better than NuScale Power › Most investors are best served by owning high-quality "forever" stocks, even if these stocks are only apt to produce average returns. Every now and then, though, there's good reason to take a shot on a higher-risk ticker with a ton of upside potential. The key is just identifying the right -- even if temporary -- growth opportunity. To this end, here's a rundown of three stocks with the potential to produce monster-sized gains over the course of the coming 10 years thanks to recent technological and sociocultural developments. There are still gains to be made past that point to be sure, but the hottest part of the underlying opportunities should be cooling off by then. After a 53-year hiatus, mankind is going back to the moon. As of its most recent plans, NASA intends to land astronauts on the moon again sometime in 2027. These missions are going to be considerably more complex than the Apollo landings in the late 1960s and early 1970s, however. This time around we're going to do far more than merely go there and come back. The next missions are ultimately laying the groundwork for future mining, scientific development, and perhaps even colonization. And NASA's using new technologies to ensure the agency gets the very most out of these expensive trips. Enter Intuitive Machines (NASDAQ: LUNR). In simplest terms, Intuitive Machines makes a great deal of the tech that will make the upcoming moon missions a success. Cargo landers, on-surface transportation drones, and in-orbit payload transfer solutions are all in its wheelhouse. It's also developing lunar-based communications satellites and mining/prospecting tools, as well as testing a fission-based power plant that could be deployed as soon as 2028. The big challenge in owning a stake in Intuitive Machines right now is a lack of profits, or for that matter, minimal revenue. Although there is some revenue being booked, this is mostly modest partnership/developmental funding that's not even fully covering the company's operating and R&D costs. There's little doubt that the bigger bucks are coming sooner than later, though. Global Market Insights expects the worldwide lunar lander and rover market alone to grow at an average annual pace of about 10% through 2034. This company's equipment just needs to start being sent into space more often -- and to the moon in particular -- to start producing a tangible and meaningful fiscal benefit. That's not going to happen in earnest until the Artemis rocket responsible for getting the next manned moon missions off the ground (literally as well as figuratively) is satisfactory reliable, along with the Orion capsule that will house actual crew members. That's apt to take until the aforementioned 2027. Just don't tarry if you're a believer. The market's got a knack for rewarding stocks based on a company's plausible future more so than its present. The proliferation of data centers (and artificial intelligence data centers in particular) has undeniably given rise to some amazing new technological tools for consumers and corporations alike. Data centers have a serious downside, though. That is, they consume a massive amount of electricity. Not only is this straining too many utility companies' power outputs, but it's environmentally unfriendly. As it turns out, the bulk of the world's current electricity production isn't yet coming from renewables. NuScale Power (NYSE: SMR) offers an optimal solution to both problems. See, this company designs and builds small-scale nuclear reactors that can be installed and operated where the electricity they generate is needed. It's not nearly as crazy as it sounds, if the fact that NuScale is far from being the only name working on such tech is any indication. Nano Nuclear and Oklo are also so-called "pure plays" within the small modular reactor (or SMR) space, while Fluor and Brookfield-owned Westinghouse are a couple of the bigger and more diversified companies also working on the idea. It's a legitimate premise, even if there's a bit more work to be done; most of that work is just clearing regulatory hurdles. Even those walls are starting to crumble, however. On Friday President Donald Trump signed an executive order to ease the regularly requirements for approving new nuclear power reactors. Although not specifically supportive of NuScale Power, it's a big step in the right direction. Now, interested investors might not want to blindly rush into a position here. This stock has outright soared just since late last week, mostly in anticipation of President Trump's executive order. Shares have more than doubled since their early April low, in fact, nearing a 52-week high as a result. Given that the company's still got years of work left to do before meaningful, profit-producing revenue starts to flow, this stock could slide just as easily as it rallied. Just keep the bigger, 10-year picture in mind, using any decent pullback as a buying opportunity. Goldman Sachs believes artificial intelligence alone is going to fuel a 165% increase in data centers' usage of electricity between now and 2030. Solar, wind, and hydro power installations on their own can't keep up with that pace. Finally, add Recursion Pharmaceuticals (NASDAQ: RXRX) to your list of monster stocks to buy and hold for the next 10 years. Just as the name suggests, Recursion is a drug company. Although it's got nothing on the market yet, it has six different drugs in early-stage trials right now. Most of these drugs are being developed in partnership with better-known pharma companies, including Sanofi, and the bulk of its R&D pipeline is aimed at cancer, where the opportunity for better treatments is always significant. That's not the compelling reason you might want to take on a 10-year stake in Recursion Pharmaceuticals, however. Rather, the reason Recursion is such a hot prospect is how it's designing and developing the drugs in its pipeline. Simply put, this company is using artificial intelligence to digitally figure out what pharmacologically works -- and what doesn't work -- before any resources are needlessly consumed. It's called Recursion OS. With 36 petabytes (36 million gigabytes) worth of proprietary data about chemical, biological, and molecular reactions ready to be accessed by a hypothetical drug-development test, pre-trial R&D work that used to require months if not years to complete can now be done in weeks, if not days. Costs that normally measure in the millions of dollars can be pared back to hundreds of thousands of dollars, or less. Recursion OS isn't a substitute for true clinical trials, to be clear -- the FDA and other regulatory agencies will still require these drugs to go through the real-world testing process. The AI-powered platform can provide a drug developer with a much better idea of what's likely to fail or succeed, though, limiting wasted resources or perhaps encouraging the development of a treatment that might have otherwise been left untreated. Like Intuitive Machines and NuScale, Recursion Pharmaceuticals is presently unprofitable, and likely to remain that way for some time. That doesn't really matter in the long run, though. Recursion Pharmaceuticals is well-positioned to lead the artificial intelligence drug discovery market that Straits Research expects to grow an annualized pace of more than 30% through 2030. That should put it on a trajectory that gets it over the profit hump. Investors are of course likely to reward mere progress toward that point in the meantime. Before you buy stock in NuScale Power, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and NuScale Power wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $639,271!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $804,688!* Now, it's worth noting Stock Advisor's total average return is 957% — a market-crushing outperformance compared to 167% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of May 19, 2025 James Brumley has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Goldman Sachs Group. The Motley Fool recommends NuScale Power. The Motley Fool has a disclosure policy. 3 Monster Stocks to Hold for the Next 10 Years was originally published by The Motley Fool
Yahoo
6 days ago
- Business
- Yahoo
NuScale Power (NYSE:SMR) Reports Improved Sales and Reduced Losses
NuScale Power recently announced two significant developments: the opening of its Energy Exploration (E2) Center at South Carolina State University and a quarterly earnings report showing improved sales and reduced losses. Despite these promising events, which could add weight to broader market movements, NuScale's 81% share price increase last month stands out against a market that saw a 3% decline over the same period. The company's recent efforts in education and financial performance seem to have positively impacted investor sentiment, distinguishing it from market trends that showed a moderate yearly upward trajectory. Be aware that NuScale Power is showing 4 weaknesses in our investment analysis. Outshine the giants: these 28 early-stage AI stocks could fund your retirement. The recent opening of NuScale Power's Energy Exploration Center and the company's improved quarterly earnings report signify a robust commitment to educational collaboration and improved financial performance. These developments could positively influence the narrative surrounding NuScale, highlighting its potential to accelerate revenue growth and enhance market positioning through strategic partnerships and technological advancements. The company's RoPower SMR technology, the ongoing project in Romania, and significant commitments towards development signal a preparedness for market entry that could bolster future earnings prospects amid broader sector growth in nuclear energy demand. Over the past year, NuScale's total shareholder return soared by 288.69%, a stark contrast to the 11.8% return of the US Electrical industry and the 9.1% overall market return within the same period. This indicates a substantial outperformance, suggesting investor confidence in the company's unique positioning and potential growth trajectory, further influenced by these strategic initiatives. The 81% share price increase last month further underscores this sentiment. The news could substantially impact revenue and earnings forecasts as the company's initiatives, such as the RoPower project, align with expectations of increased demand from sectors like AI-driven data centers. Analysts forecast a strong annual revenue growth of 121.5% over three years, although profitability remains elusive in the near term. NuScale's current share price of US$13.91 is 43.1% below the analyst consensus price target of US$24.46, suggesting possible room for appreciation driven by successful project execution and market demand fulfillment. However, potential risks such as contractual and regulatory challenges remain critical factors to monitor for their impact on financial health and timelines. Navigate through the intricacies of NuScale Power with our comprehensive balance sheet health report here. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:SMR. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
